To evaluate the availability of intra-erythrocytic oxaliplatin and plasma oxaliplatin for patients who received oxaliplatin containing adjuvant chemotherapy
Not Applicable
Recruiting
- Conditions
- Colon cancer
- Registration Number
- JPRN-UMIN000009128
- Lead Sponsor
- Tokushima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Prior chemotherapy including platinum drugs (2)HBs antigen positive, HCV antibody positive, HIV antibody positive, TPHA positive, and the active infection which needs systemic treatment (3)History of psychological disease or central nervous system disorders (4)No intention of cooperating with clinical tests in this study (5)Current or prospective enrolled in placebo controlled trial for peripheral neuropathy (6) Other conditions not suitable for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method